Biogen agrees to pay $900 million in largest FCA Settlement Ever Secured without Government’s Intervention
FDA Law
OCTOBER 3, 2022
Mr. Bawduniak alleged that, between 2009 and 2014, Biogen paid illegal kickbacks to its largest prescribers to induce them to prescribe the company’s multiple sclerosis drugs, Avonex, Tysabri and Tecfidera, and discourage them from prescribing newer competitor products. This lawsuit was brought to the U.S. See United States ex rel.
105 
Let's personalize your content